BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30290630)

  • 1. Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study.
    He X; Zhang P; Li Z; Bi F; Xu F; Wang X; Shen Y; Li Q; Qiu M
    Medicine (Baltimore); 2018 Oct; 97(40):e12601. PubMed ID: 30290630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy.
    Franzese C; Comito T; Franceschini D; Loi M; Clerici E; Navarria P; De Rose F; Di Brina L; Mancosu P; Reggiori G; Tomatis S; Scorsetti M
    J Cancer Res Clin Oncol; 2020 May; 146(5):1227-1234. PubMed ID: 32056005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
    Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
    BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer.
    Ouyang W; Yu J; Nuerjiang S; Li Z; Wang D; Wang X; Zhang J; Xie C
    Cancer Med; 2019 Aug; 8(10):4605-4614. PubMed ID: 31245933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
    Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
    Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single-institution results.
    Carvajal C; Navarro-Martin A; Cacicedo J; Ramos R; Guedea F
    J BUON; 2015; 20(1):158-65. PubMed ID: 25778311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
    Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
    Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.
    Fumagalli I; Bibault JE; Dewas S; Kramar A; Mirabel X; Prevost B; Lacornerie T; Jerraya H; Lartigau E
    Radiat Oncol; 2012 Sep; 7():164. PubMed ID: 23014094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease.
    Osti MF; Agolli L; Valeriani M; Reverberi C; Bracci S; Marinelli L; De Sanctis V; Cortesi E; Martelli M; De Dominicis C; Minniti G; Nicosia L
    Lung Cancer; 2018 Aug; 122():165-170. PubMed ID: 30032826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases.
    Kalinauskaite GG; Tinhofer II; Kufeld MM; Kluge AA; Grün AA; Budach VV; Senger CC; Stromberger CC
    BMC Cancer; 2020 May; 20(1):404. PubMed ID: 32393261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience.
    Vernaleone M; Bonomo P; Di Cataldo V; Saieva C; Masi L; Desideri I; Greto D; Francolini G; Becherini C; Livi L
    Radiol Med; 2019 Sep; 124(9):870-876. PubMed ID: 31104277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach.
    Comito T; Cozzi L; Clerici E; Campisi MC; Liardo RL; Navarria P; Ascolese A; Tozzi A; Iftode C; De Rose F; Villa E; Personeni N; Rimassa L; Santoro A; Fogliata A; Mancosu P; Tomatis S; Scorsetti M
    BMC Cancer; 2014 Aug; 14():619. PubMed ID: 25163798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-Year Outcomes of Stereotactic Body Radiotherapy for Oligometastatic Breast Cancer: Does Synchronous Oligometastatic Breast Cancer Benefit?
    Nagpal SK; Khabra K; Ross G; Kirby AM
    Clin Oncol (R Coll Radiol); 2023 Nov; 35(11):736-743. PubMed ID: 37684189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy.
    Nicosia L; Cuccia F; Mazzola R; Ricchetti F; Figlia V; Giaj-Levra N; Rigo M; Tomasini D; Pasinetti N; Corradini S; Ruggieri R; Alongi F
    Strahlenther Onkol; 2020 Sep; 196(9):813-820. PubMed ID: 32399637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
    Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy.
    Franzese C; Comito T; Toska E; Tozzi A; Clerici E; De Rose F; Franceschini D; Navarria P; Reggiori G; Tomatis S; Scorsetti M
    Radiother Oncol; 2019 Apr; 133():220-226. PubMed ID: 30414754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma.
    Yamamoto T; Niibe Y; Matsumoto Y; Onishi H; Aoki M; Nishikawa A; Oh RJ; Shintani T; Yahara K; Ozaki M; Manabe Y; Jingu K
    J Radiat Res; 2020 Nov; 61(6):935-944. PubMed ID: 32940330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic Body Radiation Therapy (SBRT) Using CyberKnife in Oligometastatic Cancer Patients; Retrospective Evaluation, Single Institution Experience.
    Alsuhaibani A; Elashwah A; Alkafi A; Constantinescus C; ALzorkany F
    J Gastrointest Cancer; 2019 Dec; 50(4):879-887. PubMed ID: 30291546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic radiation therapy in oligometastatic colorectal cancer: outcome of 102 patients and 150 lesions.
    Dell'Acqua V; Surgo A; Kraja F; Kobiela J; Zerella MA; Spychalski P; Gandini S; Francia CM; Ciardo D; Fodor C; Ferrari AM; Piperno G; Cattani F; Vigorito S; Pansini F; Petz W; Orecchia R; Leonardi MC; Jereczek-Fossa BA
    Clin Exp Metastasis; 2019 Aug; 36(4):331-342. PubMed ID: 31165360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.